Program Manager, Life Sciences at Frost & Sullivan
His industry expertise lies among life sciences engagements across various therapeutic areas, leveraging relationships with key opinion leaders in sectors such as Global Pharmaceutical & Biologics Contract Outsourcing, API manufacturing in India & China, European Oncology & Diabetes market prognosis & Pharma sales force effectiveness.
He has authored thought leadership on Biologics & Biologics Contract Manufacturing, Growth Opportunities in the EU Biosimilar Market, CRO & Bio-analytical Market, Pharmaceutical Extractables and Leachables, Cell Banking, Pharmaceutical Stability Testing and Analysis of the Global Contract Manufacturing Organization Market. In addition, he has hosted briefings with leading market participants on 'Biologics Manufacturing – Is Your Company Ready?' and 'Growth Opportunities and Disruptive Business Models Emerge in the Contract Manufacturing Organisation Market'.
Title: Data-driven Solutions Transforming the Global Biopharmaceuticals Manufacturing Industry
- Big Themes for Biologics Manufacturing
- How are Biopharma & CDMOs Responding to the Challenges and Opportunities?
- Data Driven Transformation of the Industry Ecosystem